Company / Income Tax per Share
Myriad Genetics, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.36
FY2025
5-year range
-$0.42 / $0.05
FY2021-FY2025
Trend
-857.1%
vs FY2024
Sector context
#195 of 201
Health Care
What the data says
Income Tax per Share changed -857% YoY in FY2025, a notable deviation from the 9-year average annual change of -82%.
Based on SEC 10-K filings.
-0.36 in FY2025.
Improved from $0.01 to $-0.36 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 201This company -$0.36 Sector average $1.35
▼
-126.7% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 857.1% year-over-year.
- Ranks #195 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2016.
- Lowest income tax per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.36 | -857.1% |
| FY2024 | $0.05 | +225.6% |
| FY2023 | $0.01 | +103.7% |
| FY2022 | -$0.39 | +8.1% |
| FY2021 | -$0.42 | -22.2% |
| FY2020 | -$0.35 | -226.0% |
| FY2019 | $0.27 | +245.7% |
| FY2018 | -$0.19 | -173.0% |
| FY2017 | $0.26 | -46.3% |
| FY2016 | $0.48 | -27.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026